Matches in SemOpenAlex for { <https://semopenalex.org/work/W2126568228> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2126568228 endingPage "531" @default.
- W2126568228 startingPage "525" @default.
- W2126568228 abstract "Antibodies to infliximab [ATI] and trough levels to infliximab [TRI] are associated with loss of response in inflammatory bowel diseases [IBD]. The best way to predict loss of response [LOR] to infliximab [IFX] is unknown. We conducted a prospective observational cohort study enrolling all IBD patients who were in clinical remission at Week 14 after IFX treatment initiation. TRI, ATI and C-reactive protein [CRP] level were measured at Week 22 [T1] and thereafter at every other IFX infusion. Loss of clinical response was defined by a flare requiring therapeutic change [IFX dose intensification, initiation of another drug class, and/or surgery]. A total of 93 patients [59 Crohn’s disease, mean duration of follow-up 17.2 months] were included; 32 patients [34.4%] lost clinical response during follow-up. Cumulative probability of LOR was 50% at 20 months. Mean TRI at T1 was significantly lower in IBD patients with stable ATI as compared with those with transient ATI or without ATI [0.052, 3.34 ,and 4.29 µg/ml, respectively; p = 0.001 between no ATI vs stable ATI, and p = 0.005 between stable and transient ATI] [p = 0.0001]. Three independent factors were predictive of LOR after Cox proportional hazards modelling: TRI > 5.5 µg/ml (hazard ratio [HR]: 0.21; 95% confidence interval [CI]: 0.05–0.89;p = 0.034) at T1, CRP > 5mg/l [HR: 2.5; 95% CI: 1.16–5.26; p = 0.019] at T1, and stable ATI defined by two consecutive ATI > 20ng/ml [HR: 3.77; 95% CI: 1.45–10.0; p = 0.007]. Transient ATI did not influence LOR. LOR can be predicted based on a combination of CRP, TRI and stable ATI with a high degree of accuracy." @default.
- W2126568228 created "2016-06-24" @default.
- W2126568228 creator A5005875707 @default.
- W2126568228 creator A5020258115 @default.
- W2126568228 creator A5033347563 @default.
- W2126568228 creator A5039365285 @default.
- W2126568228 creator A5042884495 @default.
- W2126568228 creator A5054195758 @default.
- W2126568228 creator A5055967992 @default.
- W2126568228 date "2015-04-19" @default.
- W2126568228 modified "2023-10-18" @default.
- W2126568228 title "Combination of C-reactive Protein, Infliximab Trough Levels, and Stable but Not Transient Antibodies to Infliximab Are Associated With Loss of Response to Infliximab in Inflammatory Bowel Disease" @default.
- W2126568228 cites W2003314961 @default.
- W2126568228 cites W2003949246 @default.
- W2126568228 cites W2017657896 @default.
- W2126568228 cites W2018178851 @default.
- W2126568228 cites W2030638161 @default.
- W2126568228 cites W2034939253 @default.
- W2126568228 cites W2056226680 @default.
- W2126568228 cites W2059843231 @default.
- W2126568228 cites W2072640801 @default.
- W2126568228 cites W2086767087 @default.
- W2126568228 cites W2087663450 @default.
- W2126568228 cites W2102245241 @default.
- W2126568228 cites W2106072130 @default.
- W2126568228 cites W2113674146 @default.
- W2126568228 cites W2124042932 @default.
- W2126568228 cites W2126807394 @default.
- W2126568228 cites W2141139109 @default.
- W2126568228 cites W2320652365 @default.
- W2126568228 cites W2331700719 @default.
- W2126568228 doi "https://doi.org/10.1093/ecco-jcc/jjv061" @default.
- W2126568228 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25895875" @default.
- W2126568228 hasPublicationYear "2015" @default.
- W2126568228 type Work @default.
- W2126568228 sameAs 2126568228 @default.
- W2126568228 citedByCount "85" @default.
- W2126568228 countsByYear W21265682282015 @default.
- W2126568228 countsByYear W21265682282016 @default.
- W2126568228 countsByYear W21265682282017 @default.
- W2126568228 countsByYear W21265682282018 @default.
- W2126568228 countsByYear W21265682282019 @default.
- W2126568228 countsByYear W21265682282020 @default.
- W2126568228 countsByYear W21265682282021 @default.
- W2126568228 countsByYear W21265682282022 @default.
- W2126568228 countsByYear W21265682282023 @default.
- W2126568228 crossrefType "journal-article" @default.
- W2126568228 hasAuthorship W2126568228A5005875707 @default.
- W2126568228 hasAuthorship W2126568228A5020258115 @default.
- W2126568228 hasAuthorship W2126568228A5033347563 @default.
- W2126568228 hasAuthorship W2126568228A5039365285 @default.
- W2126568228 hasAuthorship W2126568228A5042884495 @default.
- W2126568228 hasAuthorship W2126568228A5054195758 @default.
- W2126568228 hasAuthorship W2126568228A5055967992 @default.
- W2126568228 hasBestOaLocation W21265682281 @default.
- W2126568228 hasConcept C126322002 @default.
- W2126568228 hasConcept C188816634 @default.
- W2126568228 hasConcept C207103383 @default.
- W2126568228 hasConcept C2776914184 @default.
- W2126568228 hasConcept C2777138892 @default.
- W2126568228 hasConcept C2778260677 @default.
- W2126568228 hasConcept C2779134260 @default.
- W2126568228 hasConcept C2781195455 @default.
- W2126568228 hasConcept C44249647 @default.
- W2126568228 hasConcept C71924100 @default.
- W2126568228 hasConcept C90924648 @default.
- W2126568228 hasConceptScore W2126568228C126322002 @default.
- W2126568228 hasConceptScore W2126568228C188816634 @default.
- W2126568228 hasConceptScore W2126568228C207103383 @default.
- W2126568228 hasConceptScore W2126568228C2776914184 @default.
- W2126568228 hasConceptScore W2126568228C2777138892 @default.
- W2126568228 hasConceptScore W2126568228C2778260677 @default.
- W2126568228 hasConceptScore W2126568228C2779134260 @default.
- W2126568228 hasConceptScore W2126568228C2781195455 @default.
- W2126568228 hasConceptScore W2126568228C44249647 @default.
- W2126568228 hasConceptScore W2126568228C71924100 @default.
- W2126568228 hasConceptScore W2126568228C90924648 @default.
- W2126568228 hasIssue "7" @default.
- W2126568228 hasLocation W21265682281 @default.
- W2126568228 hasLocation W21265682282 @default.
- W2126568228 hasLocation W21265682283 @default.
- W2126568228 hasOpenAccess W2126568228 @default.
- W2126568228 hasPrimaryLocation W21265682281 @default.
- W2126568228 hasRelatedWork W1897160555 @default.
- W2126568228 hasRelatedWork W19806641 @default.
- W2126568228 hasRelatedWork W1982340782 @default.
- W2126568228 hasRelatedWork W2000293965 @default.
- W2126568228 hasRelatedWork W2072640801 @default.
- W2126568228 hasRelatedWork W2093504865 @default.
- W2126568228 hasRelatedWork W2133832905 @default.
- W2126568228 hasRelatedWork W2145199583 @default.
- W2126568228 hasRelatedWork W2409753288 @default.
- W2126568228 hasRelatedWork W4251398023 @default.
- W2126568228 hasVolume "9" @default.
- W2126568228 isParatext "false" @default.
- W2126568228 isRetracted "false" @default.
- W2126568228 magId "2126568228" @default.
- W2126568228 workType "article" @default.